Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
60.8M
-
Shares change
-
+12.6M
-
Total reported value, excl. options
-
$5.43B
-
Value change
-
+$1.15B
-
Put/Call ratio
-
0.32
-
Number of buys
-
102
-
Number of sells
-
-42
-
Price
-
$89.31
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q2 2020
168 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q2 2020.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.8M shares
of 111M outstanding shares and own 54.65% of the company stock.
Largest 10 shareholders include Venrock Management VI, LLC (9.34M shares), MORGAN STANLEY (8.22M shares), FMR LLC (7.19M shares), Foresite Capital Management II, LLC (5.5M shares), VANGUARD GROUP INC (3.96M shares), Foresite Capital Management I, LLC (3.5M shares), BlackRock Inc. (1.7M shares), SB INVESTMENT ADVISERS (UK) LTD (1.64M shares), ALLIANCEBERNSTEIN L.P. (1.53M shares), and 12 West Capital Management LP (1.44M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.